CANCER CELLS SENT INTO SPACE IN GROUNDBREAKING ROCKET EXPERIMENT
- Brian Westlake
- Apr 14
- 2 min read

In a world-first style experiment, Adelaide researchers are sending cancer cells into space, hoping the extreme conditions will unlock new ways to understand how the disease grows, adapts and survives.
Researchers from the University of Adelaide are preparing to launch living cancer cells aboard a suborbital rocket, exposing them to microgravity for just over 10 minutes in a mission that could yield insights that are impossible to replicate on Earth.
Led by Dr Nirmal Robinson from the Centre for Cancer Biology and SAHMRI’s Blood Cancer Program, the project focuses on how cancer behaves when gravity is effectively removed from the equation.
How cancer cells behave in space
The cancer cells experiment centres on microgravity, the near-weightless environment found in space, where cells behave very differently from in a lab.
On Earth, gravity forces cells to grow in flat layers. In space, they float freely, forming three-dimensional structures that more closely resemble real tumours inside the human body.
“Cancer cells live under enormous stress,” said Dr Robinson.
“In a tumour, cells are competing for nutrients and oxygen, and many die in that environment. Yet a small number of cells adapt and survive. Those are the cells that can become aggressive, spread through the body and resist treatment.”
By observing cancer cells in this altered state, researchers hope to better understand how some cells survive treatments like chemotherapy while others do not.
Why this cancer cells experiment matters
The cancer cells being studied are among the most adaptable in the body. These cells can divide indefinitely, rapidly shift behaviour, and are often responsible for tumour growth and spread.
Even when treatment is largely successful, it only takes one surviving cell to cause serious problems.
“Even when chemotherapy kills 99% of tumour cells, there can be a single cell that survives and becomes even more dangerous,” Dr Robinson said.
“If we can understand the mechanisms that allow those cells to adapt, we may be able to develop better ways to target them.”
Researchers will analyse how the cells respond upon returning to Earth, closely examining changes in gene activity and protein expression.
A rocket launch with a medical purpose
The project is supported by the South Australian Government and delivered in collaboration with Cambrian Defence & Space and Blue Dwarf Space, signalling a growing intersection between medical research and the space industry.

Opening the door to space-based science
Beyond the immediate findings, the cancer cells project is also about something bigger: giving Australian researchers more regular access to space as a testing ground.
“This project is Australia’s first dedicated microgravity cancer research mission designed to establish a repeatable, sovereign access pathway for biomedical experiments in space,” Dr Robinson said.
Cambrian Defence & Space CEO Tiffany Sharp said the goal extends beyond a single study.
“The aim is not only to advance cancer research, but also to create opportunities for other scientists and industries to use space as a laboratory.”
The mission is expected to launch later this year, with researchers hopeful the results could reshape how scientists approach one of medicine’s most complex challenges.









